A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab Emtansine

NCT00833963 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Pregnancy

Interventions

DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Ado-Trastuzumab Emtansine

Sponsor

Genentech, Inc.